Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.

Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, Brien JD, Austin SK, Diamond MS, Dermody TS, Crowe JE Jr.

Cell Host Microbe. 2015 Jul 8;18(1):86-95. doi: 10.1016/j.chom.2015.06.009. Erratum in: Cell Host Microbe. 2015 Sep 9;18(3):382. Khomadiak, Solomiia [corrected to Khomandiak, Solomiia].

2.

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

Sukupolvi-Petty S, Brien JD, Austin SK, Shrestha B, Swayne S, Kahle K, Doranz BJ, Johnson S, Pierson TC, Fremont DH, Diamond MS.

J Virol. 2013 Aug;87(16):8826-42. doi: 10.1128/JVI.01314-13. Epub 2013 Jun 19.

3.
4.

Evaluation of laparoscopic-assisted placement of jejunostomy feeding tubes in dogs.

Hewitt SA, Brisson BA, Sinclair MD, Foster RA, Swayne SL.

J Am Vet Med Assoc. 2004 Jul 1;225(1):65-71.

PMID:
15239475
5.
6.

Rubinstein-Taybi syndrome medical guidelines.

Wiley S, Swayne S, Rubinstein JH, Lanphear NE, Stevens CA.

Am J Med Genet A. 2003 Jun 1;119A(2):101-10. Review.

PMID:
12749047
7.

Lack of benefit of intravenous synthetic human secretin in the treatment of autism.

Molloy CA, Manning-Courtney P, Swayne S, Bean J, Brown JM, Murray DS, Kinsman AM, Brasington M, Ulrich CD 2nd.

J Autism Dev Disord. 2002 Dec;32(6):545-51.

PMID:
12553591

Supplemental Content

Loading ...
Support Center